ESG Data Table

The data are basically on a non-consolidated basis.

ISO26000 Core Subject

Organizational Governance

Reported Items Unit FY2025 FY2024 FY2023
Management Structure
Executive Committee Times 11 11 10
Board of Directors Times 21 21 16
Attendance Rate of Board of Directors % 97.78 98.92 99.11
Directors Persons 6 8 9
Of Which, Outside Directors Persons 2 4 4
Of Which, Female Directors Persons 0 1 1
Amount of Remuneration and the Like Millions of Yen 171 186 215
Principal Activities of Outside Directors (Excluding Directors who are Audit and Supervisory Committee Members)
Saeko Arai ー She attended all twenty-one (21) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily based on her extensive experience as a corporate executive and from the professional standpoint of a
certified public accountant. 		She attended all sixteen (16) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily based on her extensive experience as a corporate executive and from the professional standpoint of a
certified public accountant.
Nobuhiro Endo ー He attended eighteen (18) meetings out of the twenty-one
(21) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily based on his extensive experience and a broad perspective as a corporate executive. 		He attended fifteen (15) meetings out of the sixteen
(16) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily based on his extensive experience and a broad perspective as a corporate executive.
Minoru Usui He attended all twenty-one (21) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily based on his extensive experience and broad perspective as a corporate executive. He attended all twenty-one (21) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily based on his extensive experience and broad perspective as a corporate executive. He attended fifteen (15) meetings out of the sixteen
(16) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily based on his extensive experience and broad perspective as a corporate executive.
Koji Fujimoto He attended all twenty-one (21) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily based on his extensive experience and broad perspective in the healthcare field at administrative organizations. He attended all twenty-one (21) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily based on his extensive experience and broad perspective in the healthcare field at administrative organizations. He attended all sixteen (16) meetings held by the Board of Directors during the fiscal year under review, and made statements at those meetings, primarily based on his extensive experience and broad
perspective in the healthcare field at administrative
organizations.
Audit System*1
Audit & Supervisory Board Times ー 13 13
Audit & Supervisory Board Members Persons ー 5 5
Of Which, Outside Audit & Supervisory Board Members Persons ー 3 3
Amount of Remuneration and the like Millions of Yen ー 88 91
Full-Time Staff of Corporate Audits' Office Persons ー 1 1
Audit & Supervisory Board and Audit and Supervisory Committee Times 13 ー ー
Directors who are Audit and Supervisory Committee Members Persons 4 ー ー
Of Which, Member, Board of Directors (Outside Director) Audit and Supervisory Committee Member Persons 3 ー ー
Amount of Remuneration and the like Millions of Yen 53 ー ー
Full-Time Staff of Audit and Supervisory Committee Office Persons 1 ー ー
Principal Activities of Outside Directors who are Audit and Supervisory Committee Members
Yoshio Iteya He attended nineteen (19) meetings out of the twenty-one (21) meetings held by the Board of Directors, all three (3) meetings held by the Audit and Supervisory Board and all ten (10) meetings held by the Audit and Supervisory Committee during the fiscal year under review. He made statements at those meetings, primarily from the professional standpoint of an attorney. He attended all twenty-one (21) meetings held by the Board of Directors and all thirteen (13) meetings held by the Audit and Supervisory Board during the fiscal year under review. He made statements at those meetings, primarily from the professional standpoint of an attorney. He attended all sixteen (16) meetings held by the Board of Directors and all thirteen (13) meetings held by the Audit and Supervisory Board during the fiscal year under review. He made statements at those meetings, primarily from the professional standpoint of an attorney.
Mayumi Mochizuki She attended twenty (20) meetings out of the twenty-one (21) meetings held by the Board of Directors, all three (3) meetings held by the Audit & Supervisory Board and all ten (10) meetings held by the Audit and Supervisory Committee during the fiscal year under review. She made statements at those meetings, primarily from the professional standpoint of a pharmacologist. She attended all twenty-one (21) meetings held by the Board of Directors and all thirteen (13) meetings held by the Audit & Supervisory Board during the fiscal year under review. She made statements at those meetings, primarily from the professional standpoint of a pharmacologist. She attended all sixteen (16) meetings held by the Board of Directors and all thirteen (13) meetings held by the Audit & Supervisory Board during the fiscal year under review. She made statements at those meetings, primarily from the professional standpoint of a pharmacologist.
Daishiro Michimori He attended all twenty-one (21) meetings held by the Board of Directors, all three (3) meetings held by the Audit & Supervisory Board, and all ten (10) meetings held by the Audit and Supervisory Committee during the fiscal year under review. He made statements at those meetings, primarily from the professional standpoints of an expert in financial and accounting affairs and of an attorney. He attended all twenty-one (21) meetings held by the Board of Directors and all thirteen (13) meetings held by the Audit & Supervisory Board during the fiscal year under review. He made statements at those meetings, primarily from the professional standpoints of an expert in financial and accounting affairs and of an attorney. He attended all sixteen (16) meetings held by the Board of Directors and all thirteen (13) meetings held by the Audit & Supervisory Board during the fiscal year under review. He made statements at those meetings, primarily from the professional standpoints of an expert in financial and accounting affairs and of an attorney.
Communication about Compliance
Corporate CSR Blog Articles 3 8 4
Framework for Compliance Implementation
Periodic Report at Board of Directors Times 1 1 1
Compliance Committee Times 1 2 1
Compliance Committee of Group Companies in Japan Times 1 1 1
Compliance Committee of Group Companies outside Japan Times 1 1 1
Whistle-blowing Systems, Consultation Desks
Hotline and Desk
for All Officers and Employees 		Systems 6 6 6
Consulted Issues Cases 14 17 25
Compliance Education and Training
Compliance Trainings
for All Officers and Employees 		Times 7 9 7
Compliance Workshops Held at the Workplace Level
for All Workplaces 		Times 1 0 1
Compliance Workshops Held at the Group Companies
for All Group Companies 		Times 0 0 0
Harmful Incident Concerning Pharmaceuticals Workshops
for All Officers and Employees 		Times 1 1 1
Information Security Training
for All Officers and Employees 		Times 1 1 1
Stress Check
for All Employees		 Times 1 1 1
Mental Health Manager Workshops Times 1 1 1
Mental Health Self-Care Workshops Times 1 1 1
Product Recall Training in Corporate Regulatory Compliance & Quality Assurance Division Times 0 1 1
Natural Disaster Training in Risk Management Related Divisions Times 4 2 3
R&D Ethics e-Learning
for Researchers Who Are Recommended to Take the Course on the Job 		Times 1 1 1
  • *1FY2023, FY2024: Company with an Audit & Supervisory Board. Effective June 26, 2025: Company with an Audit and Supervisory Committee.

Human Rights

Reported Items Unit FY2025 FY2024 FY2023
Initiative to Respect Human Rights
Human Rights Workshops
for All Officers and Employees 		Times 1 1 1
Harmful Incident Concerning Pharmaceuticals Workshops
for All Officers and Employees 		Times 1 1 1
Initiative to Prevent Harassment
Number of People in Charge of the General Consultation Desk Persons 2 2 2
Number of People in Charge of the Harassment Consultation Desk
(Within the Company) 		Persons General Desk: 2
5 Working Place Desks: 13		 General Desk: 2
5 Working Place Desks: 12		 General Desk: 3
7 Working Place Desks: 17
Number of People in Charge of the Harassment Consultation Desk
(Workers Union) 		Persons General Desk: ４
10 Working Place Desks: 10		 General Desk: ４
10 Working Place Desks: 10		 General Desk: ４
11 Working Place Desks: 11

Labour Practices

  • The environmental performance indicators marked with have received third-party assurance.
Reported Items Unit FY2025 FY2024 FY2023
Basic Human Resources Data (Consolidated)
Number of Employees (Consolidated) as of March 31 Persons 3,123 3,832 4,980
Men Persons 1,884 2,219 3,099
Women Persons 1,238 1,612 1,881
Other Persons 1 1 －
Proportion of Women % 39.6 42.1 37.8
Basic Human Resources Data (Non-Consolidated)
Number of Employees (Non-Consolidated) as of March 31 Persons 1,747 1,799 2,908
Men Persons 1,247 1,284 2,166
Women Persons 500 515 742
Proportion of Women % 28.6 28.6 25.5
Managers
as of April 1 of the Following Fiscal Year 		Persons 266 240 346
Proportion of Female Managers
as of April 1 of the Following Fiscal Year 		% 15.4 15.0 13.7
Gender Wage Gap (All Workers)*1 % 82.9 84.1 81.9
Gender Wage Gap (Permanent Workers)*1 % 84.7 86.0 84.0
Gender Wage Gap (Part-Time Workers and Fixed-Term Workers)*1 % 43.5 56.7 91.3
MRs in Japan, including Managers Persons 510 450 1,000
MRs in Japan, excluding Managers Persons 460 390 910
Average Age Years 44.5 43.7 44.3
Average Length of Continuous Employment Years 18.9 18.4 18.7
Recruitment of New Graduates Persons 10 40 48
Proportion of Women in New Graduates Recruitment % 20.0 47.5 37.5
Recruitment of Mid Career Persons 28 8 24
Proportion of Recruitment of Mid Career % 73.7 16.6 33.3
Employment Rate of Persons with Disabilities as of June 1, Every Fiscal Year % 2.66 2.66 2.61
Employee Turnover Rate of Employees Leaving for Personal Reasons % 15.9 15.9 3.96
Retention Rate of New Graduates 3 Years after Joining the Company % 83.3 57.1 81.3
Labour Union Participating Rate Eligibility Conducted by Collective Agreement Article 3-1 % 100 100 100
Total Actual Working Hours
per Year		 Hours 1,867.8 1,797.7 1,848.0
Average Overtime Hours per Month Hours 4.2 3.5 3.6
Average Usage of Paid Leave Days / Person 14.7 15.1 15.7
Paid Leave Acquisition Rate % 73.4 75.6 78.1
Male Employees Taking Childcare Leave*2 Persons 23 34 71
Childcare Leave Usage Rate (Male Employees)*2 % 100.0 100.0 104.4
Female Employees Taking Childcare Leave*2 Persons 17 29 31
Utilization of Shorter Working Hours for Childcare Persons 73 79 85
Utilization of Leave for Nursing Care Persons 0 1 0
Utilization of Shorter
Workdays for Nursing Care 		Persons 0 3 3
Mental Illness Leave (≧30days) Persons 12 9 12
Health and Safety Management
Stress Check for All Employees Times 1 1 1
Mental Health Manager Workshops Times 1 1 1
Mental Health Self-Care Workshops Times 1 1 1
Whole Company No-Overtime Day Days 1 1 1
Work-Related Accident Frequency Rate (Non-Consolidated) ー
1.53 		1.22 1.34
Work-Related Accident Frequency Rate (Non-Consolidated)
excluding Accidents Involving Business Vehicles 		ー
1.53 		1.22 0.83
Lost-Time Injuries Frequency Rate (Non-Consolidated) ー
0.26 		1.01 0.00
Lost-Time Injuries Frequency Rate (Non-Consolidated)
excluding Accidents Involving Business Vehicles 		ー
0.26 		1.01 0.00
Lost-Time Injuries Frequency Rate (Consolidated) ー
0.28 		0.43 0.17
Lost-Time Injuries Frequency Rate (Contractors) ー
0.00 		4.38 0.00
Fatalities (Consolidated) Persons
0 		0 0
Fatalities (Contractors) Persons
0 		0 0
Communication with Employees
Company-wide Engagement Survey (SMP Opinion)*3 Times － － 1
Response Rate % － － 98.2
Opinions toward Management Cases － － 731
Proposals Made to Address Issues and/or Offer Solutions at Respective Divisions/Departments Cases － － 799
Employee Survey on Company Management*3 Times 3 1 －
Response Rate % 65.7 69.2 －
  • *1Regarding the gender wage gap, our wage system is based on the grade of the role (job) in which each employee is engaged, and there is no difference in base wages for male and female employees in the same grade; however, the following factors contribute to the differences in their average annual wages. Employees who do not receive their wages due to absenteeism, absence from work or temporary retirement are excluded from the calculation.
    Among permanent workers, the fact that the percentage of female employees in general office work positions is higher than that of male employees is the main factor in the gender wage gap. As for part time workers and fixed-term workers, the majority of them are part time workers; and, the wage levels for part time workers are lower than those for employees rehired after retirement and contract workers, due to reasons such as differences in job level and working hours. The fact that these part time workers are all female workers is a factor contributing to the gender wage gap.
  • *2The number of employees excluding seconded employees is listed.
  • *3Starting from fiscal year 2024, the company shifted from the 'Company-wide Engagement Survey(SMP Opinion)' to a new 'Employee Survey on Company Management'.

The Environment

  • The environmental performance indicators marked with have received third-party assurance.
Reported Items Unit FY2025 FY2024 FY2023
Environmental Management
Environmental and Safety Committee Times 1 2 2
Environmental and Safety Managers' Conference Times 2 2 2
Environment, Health and Safety Audit Business units 5 5 6
Follow-up Activities for Environment, Health and Safety Audit Cases 16 6 17
Environmental Accidents Cases 0 0 0
Violation of Environmental Laws and Regulations Involving Criminal or Non-Criminal Fines Cases 0 0 0
Energy Consumption
Total Energy Consumption MWh
198,454 		233,214 271,591
Non-Renewable Energy Consumption MWh 166,968 200,603 237,619
Renewable Energy Consumption MWh
31,487 		32,611 33,972
Amount of Purchased Electricity Derived from Renewable Energy Sources*1 MWh 31,367 32,469 33,832
Amount of Generated Electricity from the Solar Power Generating Systems MWh 119 141 140
Ratio of Used Electricity Derived from Non-fossil Energy (as Defined under the"Act on Rationalizing Energy Use and Shifting to Non-fossil Energy") % 47 45 －
CO2 Emissions*2
Scope 1 (from Energy Sources) ＋Scope 2 (Market-Based)
Total Emissions 		t-CO2
40,235 		46,257 53,920
Scope 1 (from Energy Sources) ＋Scope 2 (Location-Based)
Total Emissions 		t-CO2 54,564 61,239 70,482
Scope 1 (from Energy Sources) Emissions t-CO2
17,173 		23,101 27,093
Scope 2 (Market-Based) Emissions t-CO2
23,062 		23,157 26,827
Scope 2 (Location-Based) Emissions t-CO2 37,391 38,138 43,389
Scope 3 Emissions*3 t-CO2 320,176 268,297 355,702
Category 1 (Purchased Goods and Services) t-CO2
286,078 		229,764 305,002
Category 2 (Capital goods) t-CO2 13,007 14,740 18,623
Category 3 (Fuel- and Energy-Related Activities not Included in Scope 1 or Scope 2) t-CO2 11,125 12,613 15,017
Category 4 (Upstream Transportation and Distribution) t-CO2 606 780 820
Category 5 (Waste Generated in Operations) t-CO2 1,072 900 4,563
Category 6 (Business Travel) t-CO2 1,816 1,722 3,375
Category 7 (Employee Commuting) t-CO2 583 682 690
Category 8 (Upstream Leased Assets) t-CO2 － － －
Category 9 (Downstream Transportation and Distribution)*4 t-CO2 2,642 3,158 3,672
Category 10 (Processing of Sold Products) t-CO2 － － －
Category 11 (Use of Sold Products) t-CO2 2,617 3,426 3,554
Category 12 (End-of-Life Treatment of Sold Products) t-CO2 324 300 250
Category 13 (Downstream Leased Assets) t-CO2 306 212 136
Category 14 (Franchises) t-CO2 － － －
Category 15 (Investments) t-CO2 － － －
Amount of Water Withdrawal and Water Discharged
Total Amount of Water Withdrawal (Consolidated) t
570,602 		675,808 862,627
Ground Water t
116,890 		112,774 144,130
Third-Party Sources t
453,712 		563,034 718,497
Total Amount of Water Withdrawal (Non-Consolidated) t 553,818 643,941 831,818
Ground Water t 116,890 112,774 144,130
Third-Party Sources t 436,928 531,167 687,688
Total Amount of Water Discharged (Consolidated) t
567,462 		673,364 859,532
River t 372,733 430,752 617,860
Sewerage t 194,729 242,612 241,672
Total Amount of Water Discharged (Non-Consolidated) t 553,818 643,941 831,818
River t 372,733 430,752 617,860
Sewerage t 181,085 213,189 213,958
Raw Material Consumption
Raw Materials for Products (Excluding Metals) t 3,593 3,688 3,694
Raw Materials for Products (Metals) t 12 6 3
Total Amount of Product Containers and Packaging Materials t 619 574 511
Glass t 44 37 38
Plastic t 357 330 270
Paper t 218 207 203
PRTR Substances and VOC Substances Handled
PRTR Substances t 1,706 971 1,696
VOC Substances t 2,532 1,567 2,970
Waste
Total Amount of Waste Generated t 7,251 4,330 7,760
Amount Recycled t 6,419 3,603 6,421
Recycling Rate ％ 89 83 83
Amount of Final Disposal t 17 11 8
Final Disposal Rate ％ 0.24 0.25 0.10
Amount of Hazardous Waste Generated t 5,297 2,974 6,622
Amount of Hazardous Waste Recycled t 5,229 2,794 5,768
Final Disposal Amount of Hazardous Waste t 8 2 1
PRTR Substances t 1,594 911 1,695
Recycling Rate of Waste Plastics ％ 62 66 53
Number of High-Level PCB-Containing Equipment Units Owned Units 0 0 0
Number of Low-Level PCB-Containing Equipment Units Owned Units 0 0 4
Released into the Atmosphere
SOX t 0.0 0.5 0.4
NOX t 4.5 36.1 64.1
Dust Emissions t 0.2 0.3 0.3
PRTR Substances t 3.8 1.2 2.8
VOC Substances t 79.7 8.8 20.2
Released into Water Systems
BOD t 0.1 0.2 0.4
COD t 1.9 2.9 4.8
Phosphorus t 0.0 0.1 0.1
Nitrogen t 0.5 0.8 0.6
PRTR Substances t 8.4 0.0 0.0
Environmental Accounting
Environmental Investment Millions of Yen 57 531 159
Environmental Expenditure Millions of Yen 988 797 1,021
Economic Effect Millions of Yen 40 39 36
Application of Environmental Conservation Systems
Green Procurement (Green Purchasing Ratio of Office Supplies) ％ 52 50 51
Green Logistics Initiatives 44 43 43
Green Product Development Initiatives 33 26 29
Green Facilities Design Initiatives 20 16 15
Environmental Considerations for Business Vehicles
Percentage of Business Vehicles Shifted to Hybrid(HVs) or Electric Vehicles(EVs) % 97 95 －
Number of Electric Vehicles (EVs) in Our Business Vehicles Vehicles 0 10 11
Communications with Group Companies
Meeting to Exchange Information on Environment and Safety between Group Companies in Japan Times 0 1 1
Environment, Health and Safety Audits Conducted for Group Companies in Japan Companies 0 1 1
Environment, Health and Safety Audits Conducted for Group Companies outside Japan Companies 0 0 0
Biodiversity
Owls Forest Restoration Project of Kishiwada City, Osaka*5 Times/
Participants		 － － 2/60
  • *1Including the use of Non-Fossil Certificates to reduce the CO2 emissions associated with vending machine operation（in collaboration with DyDo DRINCO,INC.'s carbon neutral initiatives）.
  • *2GHG emissions quantification is subject to uncertainty when measuring activity data, determining emission factors, and considering scientific uncertainty inherent in the Global Warming Potentials.
  • *3In conjunction with the update of Category 9 emissions for FY2024, we are also updating the total emissions for FY2024.
  • *4CO2 emissions from pharmaceutical wholesalers in FY2025 have not been disclosed. Therefore, CO2 emissions from pharmaceutical wholesalers in FY2024 were used in the calculation of CO2 emissions in FY2025. As for the sales of pharmaceutical wholesalers and the sales of our products in pharmaceutical wholesalers, the sales in FY2025 were used. Furthermore, as the CO2 emissions for the pharmaceutical wholesalers for FY2024 have been disclosed, we have revised the CO2 emissions for FY2024 to reflect this figure in our calculations.
  • *5The project came to a close in September 2023 due to some positive outcomes observed.

Fair Operating Practices

Reported Items Unit FY2025 FY2024 FY2023
Appropriate Information Disclosure and Management
Information Security Training
for All Employees 		Times 1 1 1
Violations of Code of Conduct
Number of Serious Compliance
Violations		 Times 0 0 0

Consumer Issues

Reported Items Unit FY2025 FY2024 FY2023
Initiatives to Provide Stable Supplies
Plant in Japan Sites 2 2 2
Distribution Center in Japan Sites 2*1 2 2
Initiatives to Ensure Safety of Pharmaceuticals
Product Recall Training in Corporate Regulatory Compliance & Quality Assurance Division Times 0 1 1
Harmful Incident Concerning Pharmaceuticals Workshops
for All Employees 		Times 1 1 1
Initiatives to Improve Access to Medicines
Responding to Demands for Development of Unapproved or Off-Label Drugs Cases 1 1 1
Collaborative Programs with Public Institutions to Control Malaria, Influenza and Antimicrobial Resistance (AMR) Projects 5 5 7
Fight against Counterfeit Pharmaceuticals in Collaboration with International Organizations Projects 1 1 1
Communication with Customers
Inquiries to the Product Information Center Cases Approx. 20,200 Approx. 21,700 Approx. 25,800
  • *1Outsourced to Mitsubishi Logistics Corporation from January 2026.

Community Involvement and Development

Reported Items Unit FY2025 FY2024 FY2023
Stakeholder Dialogue
Dialogue with Patients and Families
Inquiries to the Product Information Center Cases Approx. 1,000 Approx. 700 Approx. 1,100
Dialogue with Healthcare Professionals
Inquiries to the Product Information Center Cases Approx. 16,000 Approx. 17,000 Approx. 21,600
Dialogue with Collaboration Partners
Competitive Open Innovation Program Framework "PRISM"(Innovative Seeds and Innovative Drug Discovery Technology Proposal) Number of Items Under Discussion/
Number of Applications 		1/8 ー ー
Competitive Open Innovation Program Framework "PRISM"(Research Needs PresentationⅡ) Number of Acceptance/
Number of Applications		 No Recruitment No Recruitment 2/8
Competitive Open Innovation Program Framework "PRISM" (Research Needs Presentation, Joint Creation by Young Researchers) Number of Acceptance/
Number of Applications		 No Recruitment No Recruitment No Recruitment
Dialogue with Shareholders
Shareholders' Meeting Times 1 1 1
Financial Results Announcement Times 4 4 4
Meeting with Analysts and Institutional Investors Times 197 123 115
ESG Meeting Times 0 0 0
R&D Meeting Times 1 0 0
Dialogue with Employees
Company-wide Engagement Survey (SMP Opinion)*1 Times ー ー 1
Response Rate % ー ー 98.2
Opinions toward Management Cases ー ー 731
Proposals Made to Address Issues and/or Offer Solutions at Respective Divisions/Departments Cases ー ー 799
Employee Survey on Company Management*1 Times 3 1 ー
Response Rate % 65.7 69.2 ー
Supporting Activity through Employee Participation
Educational Assistance for the Next Generation
Visiting Lectures by Employees Schools 0 3 12
Biodiversity
The Owls Forest Restoration Project at the Sumitomo Pharma Forest*2 Times ー ー 2
  • *1Starting from fiscal year 2024, the company shifted from the 'Company-wide Engagement Survey(SMP Opinion)' to a new 'Employee Survey on Company Management'.
  • *2The project came to a close in September 2023 due to some positive outcomes observed.

Standards for Calculating Social Performance Indicators

Social Performance Indicators Scope of Aggregation Calculation Method, etc.
Work-Related Accident Frequency Rate Non-consolidated: Employees (including contract employees, part-timers, temporary employees, and employees seconded to the Company) at all business sites of Sumitomo Pharma and SMP Distribution Service Co., Ltd. in Japan Number of deaths and injuries due to occupational accidents with or without lost workdays, excluding commuting accidents, per 1,000,000 cumulative hours worked
Work-Related Accident Frequency Rate
excluding Accidents Involving Business Vehicles 		Non-consolidated: Employees (including contract employees, part-timers, temporary employees, and employees seconded to the Company) at all business sites of Sumitomo Pharma and SMP Distribution Service Co., Ltd. in Japan Number of deaths and injuries due to occupational accidents with or without lost workdays, excluding accidents involving business vehicles and commuting accidents, per 1,000,000 cumulative hours worked
Lost-Time Injuries Frequency Rate Non-consolidated: Employees (including contract employees, part-timers, temporary employees, and employees seconded to the Company) at all business sites of Sumitomo Pharma and SMP Distribution Service Co., Ltd. in Japan Number of deaths and injuries due to occupational accidents with one or more lost workdays, excluding commuting accidents, per 1,000,000 cumulative hours worked
Consolidated:Employees (including contract employees, part-timers, temporary employees, and employees seconded to the Company) at all business sites of Sumitomo Pharma and the Sumitomo Pharma Group's consolidated companies in Japan and abroad
Contractors: Employees of contractors (including contract employees, part-timers, temporary employees, and employees seconded to the Company) at all business sites of the Company in Japan.
Lost-time Injuries Frequency Rate
excluding Accidents Involving Business Vehicles 		Non-consolidated: Employees (including contract employees, part-timers, temporary employees, and employees seconded to the Company) at all business sites of Sumitomo Pharma and SMP Distribution Service Co., Ltd. in Japan Number of deaths and injuries due to occupational accidents with one or more lost workdays, excluding accidents involving business vehicles and commuting accidents, per 1,000,000 cumulative hours worked
Fatalities Consolidated:Employees (including contract employees, part-timers, temporary employees, and employees seconded to the Company) at all business sites of Sumitomo Pharma and the Sumitomo Pharma Group's consolidated companies in Japan and abroad Number of deaths due to occupational accidents
Contractors: Employees of contractors (including contract employees, part-timers, temporary employees, and employees seconded to the Company) at all business sites of the Company in Japan.

Standards for Calculating Environmental Performance Indicators

●Energy Consumption

Environmental Performance Indicators Scope of Aggregation Calculation Method, Emissions Intensity, etc.
Total Energy Consumption Consolidated Purchased electricity＃1＋ (purchased heat×unit calorific value+fuel consumption× unit calorific value) ÷conversion factor for "MWh" to "GJ"#2
The unit calorific values and the types of fuel to be calculated are based on the"Act on Rationalizing Energy use and Shifting to Non-fossil Energy".
As for sites for which we do not have actual energy consumption data, we have made estimates based on the energy consumption at similar sites, using floor space ratios and other factors.
#1 It includes solar power generated at our business sites.
#2 3.6GJ/MWh
Non-Renewable Energy Consumption Amount of energy consumption derived from non-renewable energy sources out of the total energy consumption
Renewable Energy Consumption Amount of energy consumption derived from renewable energy sources out of the total energy consumption
Amount of Purchased Electricity Derived from Renewable Energy Sources Amount of renewable energy-derived electricity purchased out of the renewable energy
consumption (including Non-Fossil Certificates)
Amount of Generated Electricity at the Solar Power Generating Systems Amount of solar power generated by solar power generation systems at our business sites out of the renewable energy consumption
Ratio of Used Electricity Derived from Non-fossil Energy
(as Defined under the Energy Conservation Act) 		Non-consolidated Ratio of electricity derived from non-fossil sources in total electricity usage

●CO2 Emissions

Environmental Performance Indicators Scope of Aggregation Calculation Method, Emissions Intensity, etc.
Scope 1 (from Energy Sources) ＋Scope 2 (Market-Based)
Total Emissions 		Consolidated
 Total of Scope 1 (from Energy Sources) and Scope 2 (Market-Based) emissions
Scope 1 (from Energy Sources) ＋Scope 2 (Location-Based)
Total Emissions 		Total of Scope 1 (from Energy Sources) and Scope 2 (Location-Based) emissions
Scope 1 (from Energy Sources) Emissions Fuel consumption × fuel unit calorific value × fuel CO2 emission factor
The unit calorific values and CO2 emission factors are based on "Greenhouse Gas Emissions Accounting, Reporting, and Disclosure System" which is provided in the "Act on Promotion of Global Warming Countermeasures." However, for city gas in Japan, we use basic emission factors or alternative value from "Emission Factors by Gas Suppliers (for the calculation of GHG emissions by specified emitters)" published by the Ministry of the environment and the Ministry of Economy, Trade and Industry of Japan.
As for sites for which we do not have actual fuel consumption data, we have made estimates based on the fuel consumption at similar sites, using floor space ratios and other factors.
Scope 2 (Market-Based) Emissions
and Scope 2 (Location-Based) Emissions 		Purchased electricity#3 × electricity CO2 emissions factor#4 ＋ purchased heat × heat CO2 emissions factor#5
#3 It includes solar power generated at our business sites.
#4 《Market-Based》
For domestic sites, adjusted emissions factors from "Emission Factors by Power Suppliers (for the calculation of GHG emissions by specified emitters)" published by the Ministry of the Environment and the Ministry of Economy, Trade and Industry of Japan, for overseas sites, the emissions factors by country for 2022 published by the International Energy Agency (IEA). However, we use values provided by Sumitomo Chemical Co., Ltd. for sites located on the premises of Sumitomo Chemical Co., Ltd.
《Location-Based》
For domestic sites, the national average emissions factor published by the Ministry of the Environment and the Ministry of Economy, Trade and Industry of Japan, for overseas sites, the emissions factors by country for 2022 published by the International Energy Agency (IEA).
#5 Values are based on "Greenhouse Gas Emissions Accounting, Reporting, and Disclosure System" which is provided in the "Act on Promotion of Global Warming Countermeasures." However, for heat in Japan, we use alternative value from "Emission Factors by Heat Suppliers (for the calculation of GHG emissions by specified emitters)" published by the Ministry of the environment and the Ministry of Economy, Trade and Industry of Japan. In addition, we use values provided by Sumitomo Chemical Co, Ltd. for sites located on the premises of Sumitomo Chemical Co., Ltd.
As for sites for which we do not have actual purchased electricity data, we have made estimates based on purchased electricity at similar sites, using floor space ratios and other factors.
Scope3 Emissions Refer to each category Total of Category 1 emissions to Category 15 emissions
Ministry of the Environment DB: Ministry of the Environment's "Emission Intensity Database for Calculating Greenhouse Gas Emissions etc. of Organizations through their Supply Chains" (FY2023 emissions; Ver. 3.4 applied, FY2024 emissions; Ver. 3.5 applied, FY2025 emissions; Ver. 3.6 applied)
LCI-DB: LCI Database IDEAv2 (for calculation of supply chain GHG emissions)
Category 1 (Purchased Goods and Services) Non-consolidated Calculated by multiplying the purchase price of raw and packaging materials for products and purchased products and outsourced manufacturing costs by the emissions intensity in Japanese Ministry of the Environment database
Category 2 (Capital Goods) Consolidated basis Calculated by multiplying the acquisition price of the fixed asset by the emissions intensity in Japanese Ministry of the Environment database
Category 3 (Fuel- and Energy-Related Activities not Included in Scope 1 or Scope 2) Non-consolidated Calculated by multiplying purchased electricity and steam by the emissions intensity in Japanese Ministry of the Environment database and purchased fuel by the emissions intensity in Carbon Footprint database or lifecycle inventory (LCI) database
Category 4 (Upstream Transportation and Distribution) Transport in Japan, on a non-consolidated basis Transportation：Calculated by multiplying ton/kilometer for the transportation scenario by the emissions intensity in Japanese Ministry of the Environment database and LCI database
Warehousing : Obtained primary CO₂ emissions data allocated to the company from the logistics service provider.
Category 5 (Waste Generated in Operations) Non-consolidated Calculated by multiplying the weight of waste according to type and processing method by the emissions intensity in Japanese Ministry of the Environment database
Category 6 (Business Travel) Non-consolidated Calculated by multiplying business travel expenses paid by the emissions intensity in Japanese Ministry of the Environment database
Category 7 (Employee Commuting) Non-consolidated Calculated by multiplying commuting cost according to transportation means by the emissions intensity in Japanese Ministry of the Environment database
Category 8 (Upstream Leased Assets) ー ー
Category 9 (Downstream Transportation and Distribution) Non-consolidated Calculated by multiplying CO2 emissions (estimate) per unit of sales in major drug wholesalers by sales of our products in drug wholesale segment
Category 10 (Processing of Sold Products) ー ー
Category 11 (Use of Sold Products) Non-consolidated Calculated by multiplying HFC amount in pharmaceutical MDIs (metered dose inhalers) sold by GWP
Category 12 (End-of-Life Treatment of Sold Products) Non-consolidated Calculated by multiplying the weight of the container and packaging according to material based on "Act on the Promotion of Sorted Collection and Recycling of Containers and Packaging ” by the emissions intensity in Japanese Ministry of the Environment database
Category 13 (Downstream Leased Assets) Non-consolidated Calculated by multiplying the energy consumption of the building asset owned and rented out by the conversion factors based on "Greenhouse Gas Emissions Accounting, Reporting, and Disclosure System" which is provided in "Act on Promotion of Global Warming Countermeasures"
Category 14 (Franchises) ー ー
Category 15 (Investments) ー ー

●Amount of Water Withdrawal and Wastewater Discharged

Environmental Performance Indicators Scope of Aggregation Calculation Method
Total Amount of Water Withdrawal (Consolidated) Consolidated
However, small offices are excluded. In addition, overseas consolidated subsidiaries that do not have production sites or major research facilities are excluded from the scope because they have only small offices. 		Total amount of water withdrawal of ground water and third-party sources (tap water, industrial water and pure water)
Total Amount of Water Discharged (Consolidated) Total amount of water discharged to rivers and to sewerage.
*As for sites that do not measure the amount of water discharged, the amount of water withdrawal is considered as the water discharged.
Total Amount of Water Withdrawal
(Non-Consolidated) 		Non-consolidated
However, small offices are excluded. 		Total amount of water withdrawal of ground water and third-party sources (tap water, industrial water and pure water)
Total Amount of Water Discharged
(Non-Consolidated) 		Total amount of water discharged to rivers and to sewerage.
*As for sites that do not measure the amount of water discharged, the amount of water withdrawal is considered as the water discharged.

●Raw Material Consumption

Environmental Performance Indicators Scope of Aggregation Calculation Method
Raw Materials for Products (excluding Metals) Non-consolidated Amount of consumed raw materials for products (excluding metals)
Raw Materials for Products (Metals) Amount of consumed raw materials for products (metals)
Product Containers and Packaging Materials Total amount of product containers and packaging materials used for products sold in Japan

●PRTR Substances and VOC Substances

Environmental Performance Indicators Scope of Aggregation Calculation Method
PRTR Substances Non-consolidated Total amount of substance annually handled in quantities of 1 ton or more,out of PRTR substances handled for which we submitted reports under the Japanese Act on Confirmation, etc. of Release Amounts of Specific Chemical Substances in the environment and Promotion of Improvements to the Management Thereof (PRTR Law)
VOC Substances Total amount of substance annually handled in quantities of 1 ton or more, out of 101 volatile organic compounds (VOCs), i.e. the 100 major VOCs listed by the Ministry of the Environment plus n-propyl alcohol

●Waste

Environmental Performance Indicators Scope of Aggregation Calculation Method
Total Amount of Waste Generated Non-consolidated
However, sales offices are excluded. 		Total amount of by-products and other unwanted materials generated as a result of our normal business activities (including valuable resources)
Amount Recycled Amount of waste reused, recycled, or converted to valuable resources out of the total amount of waste generated
Recycling Rate Percentage of amount of waste recycled to the total amount of waste generated
Amount of Final Disposal Amount of waste finally disposed of by landfill out of the total amount of waste generated
Final Disposal Rate Percentage of waste finally disposed of to the total amount of waste generated
Amount of Hazardous Waste Generated Amount of hazardous waste (waste classified as specially-controlled industrial waste generated) out of the total amount of waste generated
Amount of Hazardous Waste Recycled Amount of hazardous waste reused, recycled, or converted into valuable resources out of the total amount of hazardous waste generated
Final Disposal Amount of Hazardous Waste Amount finally disposed of by landfill out of the total amount of hazardous waste generated
PRTR Substances Non-consolidated Atmospheric emission of PRTR substances that we reported under the PRTR Law
Recycling Rate of Waste Plastics Non-consolidated
However, head offices and sales offices are excluded. 		Percentage of amount of waste plastics recycled to the total amount of waste plastics generated
Number of High-Level PCB-Containing Equipment Units Owned Non-consolidated Total number of high-level PCB-containing equipment units owned
Number of Low-Level PCB-Containing Equipment Units Owned Total number of low-level PCB-containing equipment units owned

●Other Indicators

・The data are basically on a non-consolidated basis.